Brivekimig Biosimilar - Anti-CD252,TNFA,ALB mAb - Research Grade, Monoclonal
Artikelnummer:
PTG-PX-TA2180
- Bilder (0)
| Artikelname: | Brivekimig Biosimilar - Anti-CD252,TNFA,ALB mAb - Research Grade, Monoclonal |
| Artikelnummer: | PTG-PX-TA2180 |
| Hersteller Artikelnummer: | PX-TA2180 |
| Alternativnummer: | PTG-PX-TA2180-50, PTG-PX-TA2180-100, PTG-PX-TA2180-1 |
| Hersteller: | ProteoGenix |
| Kategorie: | Antikörper |
| Spezies Reaktivität: | Human |
| Alternative Synonym: | anti-CD252, OX40L, TXGP1, OX40 ligand, Glycoprotein Gp34, TAX transcriptionally-activated glycoprotein 1, TNFSF4, Tumor necrosis factor ligand superfamily member 4, TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1, ALB, Albumin |
| Klonalität: | Monoclonal |
| UniProt: | P23510 |
| Puffer: | 0.01M PBS, pH 7.4 |
| Expression System: | XtenCHO |
Produktgarantie und fachkundiger Support
